direkt zum Inhalt springen

direkt zum Hauptnavigationsmenü

Sie sind hier

TU Berlin

Page Content

Pramo Molecular


Delivering Nucleic Acid Drugs

Merle Fuchs
(PhD, Dipl. Biol. Molecular Biology)
Project Management, Strategic Planning, Financing

Mona Fechler Bitteti
(M.Sc. Molecular Biology)
Quality Control

Ida Shaef
(M.Sc. Biological Chemistry)
Leader 3D Organ Models

Thomas Hiller
(PhD, M.Sc. Biotechnology)
Technical Leader


Prof. Jens Kurreck, PhD, Applied Biochemistry

Faculty III – Process Sciences
Institute of Biotechnology
Department of Applied Biochemistry

EXIST-Forschungstransfer: 01.10.2019 – 30.09.2021

Delivery systems for nucleic acid based drugs


Our idea

Pramo Molecular ("pramo" = "ferry" in Esperanto), develops covalently bound carrier molecules that transport therapeutic oligonucleotides like siRNA or antisense DNA into the target cells in a particularly efficient and compatible manner.

Transport problems across lipid membranes have prevented the use of nucleic acid agents to treat serious infectious, metabolic or cancer diseases. Pramo Molecular´s delivery molecules are particularly easy to manufacture in compliance with pharmaceuticals.

During our preclinical development we are also using humanized and murine 3D tissue models to limit animal testing.


Zusatzinformationen / Extras

Quick Access:

Schnellnavigation zur Seite über Nummerneingabe

Auxiliary Functions

This site uses Matomo for anonymized webanalysis. Visit Data Privacy for more information and opt-out options.